Article

A Pharmacist-Led Model of Medication Management Service Integrated with Critical Illness Insurance Program Review: A Prospective Evaluation in Non–Small Cell Lung Cancer

2025-10-23

Abstract excerpt

<title>Abstract</title> <p>Background Non–small cell lung cancer (NSCLC) is a leading cause of cancer incidence and mortality worldwide. Targeted therapies have improved outcomes, yet challenges remain, including poor adherence, drug-related problems (DRPs), and inadequate management of adverse events. Meanwhile, the critical illness insurance program (CIIP) alleviates financial burdens but is often misaligned wi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5053b4ee-152e-5473-9a76-d3bf5be08ee1
DOI: 10.21203/rs.3.rs-7605508/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Pharmacist-Led Model of Medication Management Service Integrated with Critical Illness Insurance Program Review: A Prospective Evaluation in Non–Small Cell Lung CancerDOI 10.21203/rs.3.rs-7605508/v1Read

Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors.Semantic proximity Read

Clinical and Economic Outcomes of Virtual vs. In-Person Transplant Pharmacotherapy Clinics: A Cross-Sectional Study in IranSemantic proximity Read

Anticancer Drug Utilization and Prescription Practices in a Saudi Cancer Center (2014-2022)Semantic proximity Read

Quantifying the Dual Value and Governance Risks of Early Access Programs in Oncology: A Single-Centre Analysis and National Policy FrameworkSemantic proximity Read

Understanding the medication experience of patients with advanced non-small cell lung cancer taking epidermal growth factor receptor-tyrosine kinase inhibitors: A phenomenological study.Semantic proximity Read

Assessment of anticancer drug utilization pattern and patients’ survival—A single center experience from Saudi ArabiaSemantic proximity Read

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study.Semantic proximity Read

The impact of including a medication review in an integrated care pathway: a pilot studySemantic proximity Read

A Qualitative Research Exploring the Experiences of Patients Receiving Immune Checkpoint Inhibitors for Advanced Lung CancerSemantic proximity Read

Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible DocumentationSemantic proximity Read

Innovative Primary Care Clinic for Complex Patients Generates a Financial Benefit for Health SystemSemantic proximity Read

Influence of Health Insurance Type on the Access of Cancer Patients to Ramucirumab Therapy Using <em>All of Us</em> DatabaseSemantic proximity Read